Results 201 to 210 of about 3,173,890 (267)

The augment effects of magnesium hydride on the lipid lowering effect of atorvastatin: an in vivo and in vitro investigation. [PDF]

Med Gas Res
Chen W, Zhang Y, Miao G, Ying Y, Ren Z, Sun X, Cai J, Shen H, Lu H.   +8 more
europepmc   +1 more source

Association between lipid-lowering drug targets and the risk of cystic kidney disease: a drug-target Mendelian randomization analysis. [PDF]

Ren Fail
Lian Z, Liang Z, Chen Q, Xie C, Kong Y.
europepmc   +1 more source

Hypertriglyceridemia Therapy: Past, Present and Future Perspectives. [PDF]

Int J Mol Sci
Canfora I, Pierno S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents.

Metabolic Syndrome and Related Disorders, 2014
Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity.
A. Rizvi, D. Nikolić, H. Sallam, G. Montalto, M. Rizzo, N. Abate   +5 more
semanticscholar   +5 more sources

Perspectives of the non-statin hypolipidemic agents.

Pharmacology & Therapeutics, 2010
This review focuses on the non-statin strategies for the treatment of hyperlipidemias in humans. Even if statins remain the major hypolipidemic drugs at present, an increasing number of patients that are treated with statins raises as well the numbers of patients suffering from side effects or not responding well to the therapy.
D. Rozman, K. Monostory
semanticscholar   +4 more sources

Novel euglycemic and hypolipidemic agents. 1.

Journal of Medicinal Chemistry, 1998
A series of [[(heterocyclyl)ethoxy]benzyl]-2,4-thiazolidinediones have been synthesized by the condensation of corresponding aldehyde 1 and 2,4-thiazolidinedione followed by hydrogenation.
B. Lohray, V. Bhushan, B. P. Rao, G. R. Madhavan, N. Murali, K. Rao, Ananth K. Reddy, B. Rajesh, P. G. Reddy, R. Chakrabarti, R. Vikramadithyan, R. Rajagopalan, R. Mamidi, H. Jajoo, S. Subramaniam   +14 more
semanticscholar   +4 more sources

Biological Evaluation of Chalcones and Analogues as Hypolipidemic Agents

Archiv der Pharmazie, 2006
AbstractIn order to evaluate the anti‐hyperlipidemic effect of synthetic chalcones and some analogues, nineteen compounds with different substituents in both rings were synthesized and hypolipidemic activities were measured in vivo using Triton WR1339 acute and hypercaloric chronic assays.
Lorena Santos, Rozangela Curi Pedrosa, R. Corrêa, V. Cechinel Filho, R. Nunes, R. Yunes   +5 more
semanticscholar   +4 more sources

Studies of hypolipidemic agents. 1. Synthesis and hypolipidemic activities of alkoxycinnamic acid derivatives.

Journal of Medicinal Chemistry, 1980
More than 110 derivatives of alkoxycinnamic acids were synthesized and their hypolipidemic activities were evaluated in a screening system with rats. Cinnamic acids, alpha-methylcinnamic acids, and their various esters with a higher p-alkoxy substituent ...
T. Watanabe, K. Hayashi, S. Yoshimatsu, K. Sakai, S. Takeyama, K. Takashima   +5 more
semanticscholar   +5 more sources